167 related articles for article (PubMed ID: 17868016)
1. Recent advances in genetic analysis of multiple sclerosis: genetic associations and therapeutic implications.
Niino M; Fukazawa T; Kikuchi S; Sasaki H
Expert Rev Neurother; 2007 Sep; 7(9):1175-88. PubMed ID: 17868016
[TBL] [Abstract][Full Text] [Related]
2. The role of non-HLA single nucleotide polymorphisms in multiple sclerosis susceptibility.
Bahreini SA; Jabalameli MR; Saadatnia M; Zahednasab H
J Neuroimmunol; 2010 Dec; 229(1-2):5-15. PubMed ID: 20832869
[TBL] [Abstract][Full Text] [Related]
3. Genetic association between polymorphisms in the BTG1 gene and multiple sclerosis.
Camiña-Tato M; Morcillo-Suárez C; Navarro A; Fernández M; Horga A; Montalban X; Comabella M
J Neuroimmunol; 2009 Aug; 213(1-2):142-7. PubMed ID: 19515430
[TBL] [Abstract][Full Text] [Related]
4. SNP mapping and candidate gene sequencing in the class I region of the HLA complex: searching for multiple sclerosis susceptibility genes in Tasmanians.
Burfoot RK; Jensen CJ; Field J; Stankovich J; Varney MD; Johnson LJ; Butzkueven H; Booth D; Bahlo M; Tait BD; Taylor BV; Speed TP; Heard R; Stewart GJ; Foote SJ; Kilpatrick TJ; Rubio JP
Tissue Antigens; 2008 Jan; 71(1):42-50. PubMed ID: 17971048
[TBL] [Abstract][Full Text] [Related]
5. EVI5 is a risk gene for multiple sclerosis.
Hoppenbrouwers IA; Aulchenko YS; Ebers GC; Ramagopalan SV; Oostra BA; van Duijn CM; Hintzen RQ
Genes Immun; 2008 Jun; 9(4):334-7. PubMed ID: 18401352
[TBL] [Abstract][Full Text] [Related]
6. Fine mapping of multiple sclerosis susceptibility genes provides evidence of allelic heterogeneity at the IL2RA locus.
Perera D; Stankovich J; Butzkueven H; Taylor BV; Foote SJ; Kilpatrick TJ; Rubio JP
J Neuroimmunol; 2009 Jun; 211(1-2):105-9. PubMed ID: 19375175
[TBL] [Abstract][Full Text] [Related]
7. [Genetic susceptibility to multiple sclerosis (MS). INSERM Network of Clinical Research on the Genetic Susceptibility to MS].
Fontaine B
Rev Neurol (Paris); 1998 Sep; 154(8-9):601-5. PubMed ID: 9809375
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis.
Byun E; Caillier SJ; Montalban X; Villoslada P; Fernández O; Brassat D; Comabella M; Wang J; Barcellos LF; Baranzini SE; Oksenberg JR
Arch Neurol; 2008 Mar; 65(3):337-44. PubMed ID: 18195134
[TBL] [Abstract][Full Text] [Related]
9. Effect of BSN-MST1 locus on inflammatory bowel disease and multiple sclerosis susceptibility.
Márquez A; Cénit MC; Núñez C; Mendoza JL; Taxonera C; Díaz-Rubio M; Bartolomé M; Arroyo R; Fernández-Arquero M; de la Concha EG; Urcelay E
Genes Immun; 2009 Oct; 10(7):631-5. PubMed ID: 19657358
[TBL] [Abstract][Full Text] [Related]
10. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis.
Oksenberg JR; Baranzini SE; Sawcer S; Hauser SL
Nat Rev Genet; 2008 Jul; 9(7):516-26. PubMed ID: 18542080
[TBL] [Abstract][Full Text] [Related]
11. IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations.
Weber F; Fontaine B; Cournu-Rebeix I; Kroner A; Knop M; Lutz S; Müller-Sarnowski F; Uhr M; Bettecken T; Kohli M; Ripke S; Ising M; Rieckmann P; Brassat D; Semana G; Babron MC; Mrejen S; Gout C; Lyon-Caen O; Yaouanq J; Edan G; Clanet M; Holsboer F; Clerget-Darpoux F; Müller-Myhsok B
Genes Immun; 2008 Apr; 9(3):259-63. PubMed ID: 18354419
[TBL] [Abstract][Full Text] [Related]
12. COX-2 promoter region polymorphisms in multiple sclerosis: lack of association of -765G>C with disease risk.
Mazzola S; Lira MG; Benedetti MD; Salviati A; Ottaviani S; Malerba G; Ortombina M; Pignatti PF
Int J Immunogenet; 2007 Apr; 34(2):71-4. PubMed ID: 17373929
[TBL] [Abstract][Full Text] [Related]
13. Genetic risk factors in multiple sclerosis and approaches to their identification.
Rasmussen HB; Clausen J
J Neurovirol; 2000 May; 6 Suppl 2():S23-7. PubMed ID: 10871780
[TBL] [Abstract][Full Text] [Related]
14. The genetics of multiple sclerosis.
Compston A
J Neurovirol; 2000 May; 6 Suppl 2():S5-9. PubMed ID: 10871776
[TBL] [Abstract][Full Text] [Related]
15. Multiple sclerosis genetics: leaving no stone unturned.
Oksenberg JR; Barcellos LF
Genes Immun; 2005 Aug; 6(5):375-87. PubMed ID: 15973459
[TBL] [Abstract][Full Text] [Related]
16. The autoimmune disease-associated IL12B and IL23R polymorphisms in multiple sclerosis.
Begovich AB; Chang M; Caillier SJ; Lew D; Catanese JJ; Wang J; Hauser SL; Oksenberg JR
Hum Immunol; 2007 Nov; 68(11):934-7. PubMed ID: 18082575
[TBL] [Abstract][Full Text] [Related]
17. [Genetic predisposition for multiple sclerosis].
Fontaine B; Clerget-Darpoux F
Pathol Biol (Paris); 2000 Feb; 48(1):87-92. PubMed ID: 10729916
[TBL] [Abstract][Full Text] [Related]
18. CASP-9: A susceptibility locus for multiple sclerosis in Italy.
Andreoli V; Trecroci F; La Russa A; Valentino P; Condino F; Latorre V; Nisticò R; Pirritano D; Del Giudice F; Canino M; Cittadella R; Quattrone A
J Neuroimmunol; 2009 May; 210(1-2):100-3. PubMed ID: 19359048
[TBL] [Abstract][Full Text] [Related]
19. Peripheral blood gene expression signature mirrors central nervous system disease: the model of multiple sclerosis.
Achiron A; Gurevich M
Autoimmun Rev; 2006 Oct; 5(8):517-22. PubMed ID: 17027885
[TBL] [Abstract][Full Text] [Related]
20. Variants in ST8SIA1 do not play a major role in susceptibility to multiple sclerosis in Canadian families.
Ramagopalan SV; Morrison KM; Para A; Handel A; Disanto G; Handunnetthi L; Orton SM; Sadovnick AD; Ebers GC
J Neuroimmunol; 2009 Jul; 212(1-2):142-4. PubMed ID: 19428123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
